<DOC>
	<DOCNO>NCT02755428</DOCNO>
	<brief_summary>This project intend transplant human embryonic stem cell derive retinal pigment epithelium subretinal space patient treat dry age-related macular degeneration ( dry-AMD ) .And assess safety efficacy RPE transplant treat dry AMD .</brief_summary>
	<brief_title>Subretinal Transplantation Retinal Pigment Epitheliums Treatment Age-related Macular Degeneration Diseases</brief_title>
	<detailed_description>This project intend transplant human embryonic stem cell derive retinal pigment epithelium subretinal space treat age-related macular degeneration ( AMD ) . Through statistical analysis EDTRS , BCVA , OCT , ERG , Fluorescein angiography , Ophthalmic AB ultrasound change treatment ass efficacy safety RPE transplant treat AMD disease .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Aged 5575 year ; Diagnosed atrophic agerelated macular degeneration ; No CNV ; The BCVA target eye well 20/200 ; Diopter small 8.00 D , axial length â‰¤28 mm ; voluntary test subject , sign informed consent , regular followup time . The macular atrophy cause disease addition AMD ; With history eye diseases ocular trauma ; With history intraocular surgery ; With serious system disease , ALT/AST ) &gt; 1.5 creatine &gt; 1.3 mg/dL ; With immunodeficiency disease ; Subject receive immunosuppressive therapy ; Allergic tacrolimus Mycophenolate mofetil ;</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>